GLP-1 Slows Hypoglycemia-Induced Gastric Emptying

In healthy subjects, GLP-1 attenuates accelerated gastric emptying and glucose absorption
GLP-1 Slows Hypoglycemia-Induced Gastric Emptying

THURSDAY, April 17, 2014 (HealthDay News) -- For healthy subjects, exogenous glucagon-like peptide 1 (GLP-1) attenuates hypoglycemia-induced acceleration of gastric emptying, according to a study published online March 5 in Diabetes Care.

Mark P. Plummer, M.D., from the University of Adelaide in Australia, and colleagues examined whether GLP-1 attenuates hypoglycemia-induced acceleration of gastric emptying. Ten healthy subjects received intravenous GLP-1 or placebo during hypoglycemia and euglycemia. At time 0, subjects ingested beef mince labeled with 99mTc-sulfur-colloid and a marker of glucose absorption (3-O-methyl-glucose [OMG]). Gastric emptying was measured scintigraphically through 180 minutes and 3-OMG was sampled at 15-minute intervals.

The researchers found that gastric emptying and glucose absorption were accelerated during hypoglycemia (hypoglycemia/placebo versus euglycemia/placebo; P < 0.001 and P < 0.03, respectively). During euglycemia, GLP-1 slowed gastric emptying (euglycemia/placebo versus euglycemia/GLP-1; P < 0.001). GLP-1 diminished hypoglycemia-induced acceleration of gastric emptying (hypoglycemia/placebo versus hypoglycemia/GLP-1; P < 0.008) and glucose absorption (P < 0.01).

"Acute administration of exogenous GLP-1 attenuates, but does not abolish, the acceleration of gastric emptying by insulin-induced hypoglycemia in healthy subjects," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)

Related Stories

No stories found.
logo
www.healthday.com